Study on the Efficacy and Safety of QLM1016 in Schizophrenia

NCT06799559 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: 3-6mg QLM1016
DRUG: 10-20 mg Aripiprazole oral solution film

Sponsor

Qilu Pharmaceutical Co., Ltd.